z-logo
Premium
The effect of retinoids on premalignant oral lesions
Author(s) -
Gorsky Meir,
Epstein Joel B.
Publication year - 2002
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.10874
Subject(s) - medicine , leukoplakia , vitamin , oral leukoplakia , malignant transformation , retinoic acid , gastroenterology , tretinoin , dermatology , carcinoma , carcinogenesis , cancer , oncology , pathology , biochemistry , chemistry , gene
BACKGROUND Retinoids have been studied as chemopreventive treatment for patients with oropharyngeal carcinoma. Vitamin A modulates growth and differentiation of cells, and its deficiency enhances susceptibility to carcinogenesis. The chemopreventive mechanism of action of vitamin A is discussed, and a review of clinical results and side effects of the systemic use of vitamin A is included. The objective of the current report was to review the possible role of topical vitamin A and vitamin A derivatives in the management of patients with oral lesions with a risk of transformation to carcinoma. METHODS: A Medline search was conducted and references identified within the identified papers were also reviewed. RESULTS Only four studies using topical vitamin A for patients with oral leukoplakia have been reported. A complete response was achieved in 10–27% of patients, and a partial response was achieved in 54–90% of patients; however, recurrence of leukoplakia was reported after withdrawing the medication in approximately 50% of patients. The side effects of the topical use were minimal. CONCLUSIONS Although the direct application of higher concentrations of retinoic acid results in suppression of oral leukoplakias only, its use in the treatment of patients with recurrent and persistent lesions may be justified for controlling lesions that otherwise may progress. Further controlled clinical studies are needed. Cancer 2002;95:1258–64. © 2002 American Cancer Society. DOI 10.1002/cncr.10874

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here